Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
NCT02354326 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2019-02-05
Summary
This clinical trial studies dual energy computed tomography (CT) in finding cancer that has spread from the original (primary) tumor to the bone (bone metastases) in patients with cancer. Diagnostic procedures, such as dual energy CT, may help find and diagnose bone metastases and may be more accurate compared to single energy CT alone.
Conditions
- Malignant Neoplasm
- Metastatic Malignant Neoplasm to the Bone
Interventions
- RADIATION
-
virtual non-calcium dual-energy computed tomography
Undergo VNC DECT
- RADIATION
-
computed tomography
Undergo CT without VNC
Sponsors & Collaborators
-
Case Comprehensive Cancer Center
lead OTHER -
National Cancer Institute (NCI)
collaborator NIH
Principal Investigators
-
Naveen Subhas, MD · Case Comprehensive Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-07
- Primary Completion
- 2017-09-27
- Completion
- 2017-09-27
Countries
- United States
Study Locations
More Related Trials
-
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
NCT01254929 ·Status: COMPLETED
-
NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer
NCT02103634 ·Status: COMPLETED
-
DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
NCT03685539 ·Status: COMPLETED ·Phase: NA
-
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
NCT01541358 ·Status: TERMINATED ·Phase: NA
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
NCT03145077 ·Status: RECRUITING ·Phase: NA
-
11C Topotecan PET Imaging
NCT00253461 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
NCT00414934 ·Status: UNKNOWN
-
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938 ·Status: COMPLETED
-
Diagnostic Imaging of Myeloma Bone Lesions
NCT03147326 ·Status: COMPLETED ·Phase: NA
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
NCT06455722 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
NCT04159376 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
NCT01880762 ·Status: COMPLETED
-
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
NCT02826382 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer
NCT00824213 ·Status: COMPLETED
-
A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone
NCT03557450 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort
NCT02356497 ·Status: RECRUITING
-
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
NCT00956163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
NCT02226276 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
NCT00316901 ·Status: COMPLETED ·Phase: PHASE2
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
NCT00335751 ·Status: COMPLETED ·Phase: NA
-
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 ·Status: COMPLETED ·Phase: PHASE2